MSB UC.pdf Innovative preconditioning strategies for improving the therapeutic
efficacy of extracellular vesicles derived from mesenchymal stem cells
in gastrointestinal diseases
A very good read on UC and other GD. Most importantly how MSC's target UC, and the advancement of EV's
Cell Therapy News/Articles, page-17181
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.120(9.76%) |
Mkt cap ! $1.267B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.11 | $14.06M | 12.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 168043 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 27647 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.120 ( 9.28 %) |
||||
| Open | High | Low | Volume | ||
| $1.20 | $1.20 | $1.12 | 1823761 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| MSB (ASX) Chart |